BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 30338346)

  • 1. Insulin-like growth factor-1 receptor expression in upper tract urothelial carcinoma.
    Eich ML; Tregnago AC; Faraj SF; Palsgrove DN; Fujita K; Bezerra SM; Munari E; Sharma R; Chaux A; Netto GJ
    Virchows Arch; 2019 Jan; 474(1):21-27. PubMed ID: 30338346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor messenger RNA-binding protein 3 expression helps prognostication in patients with upper tract urothelial carcinoma.
    Lee DJ; Xylinas E; Rieken M; Khani F; Klatte T; Wood CG; Karam JA; Weizer AZ; Raman JD; Remzi M; Guo CC; Rioux-Leclercq N; Haitel A; Bolenz C; Bensalah K; Sagalowsky AI; Montorsi F; Lotan Y; Shariat SF; Robinson BD; Margulis V
    Eur Urol; 2014 Aug; 66(2):379-85. PubMed ID: 24388440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTRF independently predicts progression and survival in multiracial upper tract urothelial carcinoma following radical nephroureterectomy.
    Yeh HC; Margulis V; Singla N; Hernandez E; Panwar V; Woldu SL; Karam JA; Wood CG; Weizer AZ; Raman JD; Remzi M; Rioux-Leclercq N; Haitel A; Roscigno M; Bolenz C; Bensalah K; Li CC; Ke HL; Li WM; Lee HY; Rapoport LM; Lotan Y; Kapur P; Shariat SF; Hsieh JT; Wu WJ
    Urol Oncol; 2020 May; 38(5):496-505. PubMed ID: 31862213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GATA3 immunohistochemistry in urothelial carcinoma of the upper urinary tract as a urothelial marker and a prognosticator.
    Inoue S; Mizushima T; Fujita K; Meliti A; Ide H; Yamaguchi S; Fushimi H; Netto GJ; Nonomura N; Miyamoto H
    Hum Pathol; 2017 Jun; 64():83-90. PubMed ID: 28428106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of BAP1 expression in high-grade upper tract urothelial carcinoma: a multi-institutional study.
    Aydin AM; Singla N; Panwar V; Woldu SL; Freifeld Y; Wood CG; Karam JA; Weizer AZ; Raman JD; Remzi M; Rioux-Leclercq N; Haitel A; Roscigno M; Bolenz C; Bensalah K; Westerman ME; Sagalowsky AI; Shariat SF; Lotan Y; Bagrodia A; Kapur P; Margulis V; Krabbe LM
    World J Urol; 2019 Nov; 37(11):2419-2427. PubMed ID: 30759271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic role of expression of N-cadherin in patients with upper tract urothelial carcinoma: a multi-institutional study.
    Abufaraj M; Moschini M; Soria F; Gust K; Özsoy M; Mathieu R; Rouprêt M; Margulis V; Karam JA; Wood CG; Briganti A; Bensalah K; Haitel A; Shariat SF
    World J Urol; 2017 Jul; 35(7):1073-1080. PubMed ID: 27830374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of mammalian target of rapamycin pathway in upper tract urothelial carcinoma.
    Munari E; Fujita K; Faraj S; Chaux A; Gonzalez-Roibon N; Hicks J; Meeker A; Nonomura N; Netto GJ
    Hum Pathol; 2013 Dec; 44(12):2668-76. PubMed ID: 24074531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor-1 receptor overexpression is associated with outcome in invasive urothelial carcinoma of urinary bladder: a retrospective study of patients treated using radical cystectomy.
    Gonzalez-Roibon N; Kim JJ; Faraj SF; Chaux A; Bezerra SM; Munari E; Ellis C; Sharma R; Keizman D; Bivalacqua TJ; Schoenberg M; Eisenberger M; Carducci M; Netto GJ
    Urology; 2014 Jun; 83(6):1444.e1-6. PubMed ID: 24713135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility and concordance of upper urinary tract cytology and biopsy in predicting clinicopathological features of upper urinary tract urothelial carcinoma.
    Simon CT; Skala SL; Weizer AZ; Ambani SN; Chinnaiyan AM; Palapattu G; Hafez K; Magers MJ; Kaffenberger SD; Spratt DE; Montgomery JS; Morgan TM; Udager AM; Lew M; Mehra R
    Hum Pathol; 2019 Apr; 86():76-84. PubMed ID: 30537495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Rieken M; Schubert T; Xylinas E; Kluth L; Rouprêt M; Trinh QD; Lee RK; Al Hussein Al Awamlh B; Fajkovic H; Novara G; Margulis V; Lotan Y; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Karakiewicz PI; Scherr DS; Briganti A; Bachmann A; Shariat SF;
    Eur J Surg Oncol; 2014 Dec; 40(12):1693-9. PubMed ID: 24780094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Rieken M; Xylinas E; Kluth L; Trinh QD; Lee RK; Fajkovic H; Novara G; Margulis V; Lotan Y; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Karakiewicz PI; Scherr DS; Briganti A; Kautzky-Willer A; Bachmann A; Shariat SF;
    Eur J Surg Oncol; 2014 Jan; 40(1):113-20. PubMed ID: 24113620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased nucleophosmin expression is a strong predictor of recurrence and prognosis in patients with N0M0 upper tract urothelial carcinoma undergoing radical nephroureterectomy.
    Sawazaki H; Ito K; Asano T; Kuroda K; Sato A; Asakuma J; Horiguchi A; Seguchi K; Asano T
    World J Urol; 2017 Jul; 35(7):1081-1088. PubMed ID: 27885451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of tumor size on outcomes in patients with upper urinary tract urothelial carcinoma.
    Milenkovic-Petronic D; Milojevic B; Djokic M; Sipetic-Grujicic S; Milojevic IG; Bumbasirevic U; Dzamic Z
    Int Urol Nephrol; 2014 Mar; 46(3):563-9. PubMed ID: 24057684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy.
    Chromecki TF; Cha EK; Fajkovic H; Margulis V; Novara G; Scherr DS; Lotan Y; Raman JD; Kassouf W; Bensalah K; Weizer A; Kikuchi E; Roscigno M; Remzi M; Matsumoto K; Walton TJ; Pycha A; Ficarra V; Karakiewicz PI; Zigeuner R; Pummer K; Shariat SF
    Eur Urol; 2012 Feb; 61(2):245-53. PubMed ID: 21975249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC).
    Soria F; Moschini M; Haitel A; Wirth GJ; Karam JA; Wood CG; Rouprêt M; Margulis V; Karakiewicz PI; Briganti A; Raman JD; Kammerer-Jacquet SF; Mathieu R; Bensalah K; Lotan Y; Özsoy M; Remzi M; Gust KM; Shariat SF
    World J Urol; 2017 Feb; 35(2):251-259. PubMed ID: 27272502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strong association of insulin-like growth factor 1 receptor expression with histologic grade, subtype, and HPV status in penile squamous cell carcinomas: a tissue microarray study of 112 cases.
    Faraj SF; Gonzalez-Roibon N; Munari E; Sharma R; Burnett AL; Cubilla AL; Netto GJ; Chaux A
    Virchows Arch; 2017 Jun; 470(6):695-701. PubMed ID: 28349238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery.
    Rink M; Ehdaie B; Cha EK; Green DA; Karakiewicz PI; Babjuk M; Margulis V; Raman JD; Svatek RS; Fajkovic H; Lee RK; Novara G; Hansen J; Daneshmand S; Lotan Y; Kassouf W; Fritsche HM; Pycha A; Fisch M; Scherr DS; Shariat SF; ;
    Eur Urol; 2012 Oct; 62(4):677-84. PubMed ID: 22349570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoglin expression in upper urinary tract urothelial carcinoma is associated with intravesical recurrence after radical nephroureterectomy.
    Fujita K; Ujike T; Nagahara A; Uemura M; Tanigawa G; Shimazu K; Fushimi H; Yamaguchi S; Nonomura N
    Int J Urol; 2015 May; 22(5):463-7. PubMed ID: 25631522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of KPNA2 defines poor prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Shi B; Su B; Fang D; Tang Y; Xiong G; Guo Z; He Q; Yang X; Zhao W; Guo Y; Li X; Zhou L
    BMC Cancer; 2015 May; 15():380. PubMed ID: 25956057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
    Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; Martínez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W
    BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.